Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery.
about
Stimuli-Responsive Polymeric Systems for Controlled Protein and Peptide Delivery: Future Implications for Ocular DeliveryAdvanced drug delivery and targeting technologies for the ocular diseasesTowards the use of hydrogels in the treatment of limbal stem cell deficiencyIntraocular pressure changes: an important determinant of the biocompatibility of intravitreous implantsIn vivo NIR imaging with PbS quantum dots entrapped in biodegradable micelles.Biodegradable thermogelling polymers: working towards clinical applications.Adaptable hydrogel networks with reversible linkages for tissue engineering.Enhanced and sustained topical ocular delivery of cyclosporine A in thermosensitive hyaluronic acid-based in situ forming microgelsRecent perspectives in ocular drug delivery.Biodegradable in situ gelling delivery systems containing pilocarpine as new antiglaucoma formulations: effect of a mercaptoacetic acid/N-isopropylacrylamide molar ratioNANOTECHNOLOGY IN THE TREATMENT AND DETECTION OF INTRAOCULAR CANCERS.Ocular microdialysis: a continuous sampling technique to study pharmacokinetics and pharmacodynamics in the eye.Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications.In situ gel systems as 'smart' carriers for sustained ocular drug delivery.Ocular drug delivery system: a reference to natural polymers.Advancement in stimuli triggered in situ gelling delivery for local and systemic route.Novel strategies for anterior segment ocular drug delivery.Thermoresponsive polymers as gene and drug delivery vectors: architecture and mechanism of action.Challenges and solutions in topical ocular drug-delivery systems.Topical delivery of ocular therapeutics: carrier systems and physical methods.Advances in ophthalmic drug delivery.Medical management of glaucoma: focus on ophthalmologic drug delivery systems of timolol maleate.Stimuli-Sensitive Injectable Hydrogels Based on Polysaccharides and Their Biomedical Applications.Approaches in topical ocular drug delivery and developments in the use of contact lenses as drug-delivery devices.In situ gelling gelrite/alginate formulations as vehicles for ophthalmic drug delivery.Dual-Drug Containing Core-Shell Nanoparticles for Lung Cancer TherapyEvaluation of the biocompatibility of novel peptide hydrogel in rabbit eye.Reversed lipid-based nanoparticles dispersed in oil for malignant tumor treatment via intratumoral injection.Chitosan temperature-sensitive gel loaded with drug microspheres has excellent effectiveness, biocompatibility and safety as an ophthalmic drug delivery system.Ophthalmic Drug Delivery Systems for Antibiotherapy-A Review.Injectable hydrogels for ophthalmic applications.Preparation and evaluation of novel chitosan: gelrite ocular system containing besifloxacin for topical treatment of bacterial conjunctivitis: scintigraphy, ocular irritation and retention assessment.Hydrogels: an interesting strategy for smart drug delivery.Designing hydrogels for controlled drug delivery.Evaluation of a novel oxiconazole nitrate formulation: The thermosensitive gel.A biodegradable thermosensitive hydrogel with tuneable properties for mimicking three-dimensional microenvironments of stem cellsStimulation-Sensitive Drug Delivery SystemsEffect of intermolecular and intramolecular forces on hydrodynamic diameters of poly(N-isopropylacrylamide) copolymers in aqueous solutionsSmart carboxymethylchitosan hydrogels that have thermo- and pH-responsive propertiesHydrogels in mucosal delivery
P2860
Q26740005-7D94ADCB-EC97-4400-8B21-414E927ECF96Q26747220-DF9AD3B7-0C2C-4AE7-8FA3-4F0EE18E9B81Q27010179-F8622547-1A1D-4B78-9B9F-BF4B710FF2D8Q28478420-E4E7F753-B7C2-4EA0-927E-C55DD1F554A5Q34139728-A02B1123-5A1C-4BCA-B238-2F2C85D097EDQ34401689-2805DAC1-68B5-4602-B6DE-78EDEB69FE0DQ35927889-87EC25BE-3B64-4F7F-893C-0A3833A62381Q37211072-D30A000C-33C5-43FB-98C1-6242D2F98FE1Q37256549-0FF4CAF5-1FCD-4729-85A6-57EFC63E487AQ37260923-E8192CF2-7AA5-42D8-A071-0C6D84962D7DQ37776418-2E96FDCC-6F4E-407B-8C60-80AD6DB9D8F2Q37810236-4C69718C-30BA-49E5-A2CA-A6D947A3C7C1Q37960809-E7D6C60B-7DB7-4E4C-9B72-584A414D9F74Q37995297-AB72C4A1-879B-4F9D-BC3B-9C4869E715CDQ38019052-C30537E0-2D88-4BE3-8BB7-5E0CFB15F61CQ38052935-05577636-C15A-4AED-9FEF-033E808902C7Q38065184-BE278CDF-1F99-418A-BFA9-B798C1AC9E40Q38152507-4B578C81-91C6-4FC0-943C-1BCD4733C322Q38177335-1F5E951D-E089-4930-A55E-250ADB25E2E1Q38196446-B3F354A1-1500-4729-93D4-75984C212C65Q38297129-DDAF3205-E204-4DBC-ACCE-44E04F24F62CQ38784707-C1ABC288-149A-4314-A36D-8DB12EF53DACQ38810086-D3C47808-BC2B-4C79-81F9-C9AD9C2ECE22Q39386513-CB31C55D-2097-43C6-AFB8-8ADFDB816A95Q41822958-52B9260C-88C8-43A3-B3C7-31081CB49E13Q42379033-8DA2B7A6-3923-453A-93CE-0197E4374D24Q43131969-D04D3D06-861A-4772-9037-ADDF260E63E8Q48792087-9956CEA0-6D5E-41E5-B673-4955E44594FDQ49420970-E6AC5974-CDF5-420E-9659-6B5A816AB568Q49996892-A5AAF4C5-A971-40BE-8A9C-87CC2993947EQ50072638-E56B4C46-390A-47FE-82D6-065FC6FD1821Q50529018-0DCAEF7B-03C2-43B9-B098-1AF115CA6922Q51836270-2DAED0AA-1E66-45BA-988E-5838F5286098Q55264903-E08126CE-5016-479A-BB36-8D192A93349EQ55510215-337BA053-7B72-46A3-8B2C-95068CDD68CEQ56077645-3383D0F0-6DAC-4B7E-AE05-5D166917BF2FQ57341240-59E09623-4EDD-4BDD-A500-047F92C01275Q57348266-3DB59FFC-CD3E-4222-90F2-43BCD4316783Q57348357-F801763C-ED82-45EA-93C2-6046F2312B6DQ57350262-896847E8-63DA-4637-BFC8-ABE5170E8109
P2860
Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Poly(N-isopropylacrylamide)-ch ...... stem for ocular drug delivery.
@en
type
label
Poly(N-isopropylacrylamide)-ch ...... stem for ocular drug delivery.
@en
prefLabel
Poly(N-isopropylacrylamide)-ch ...... stem for ocular drug delivery.
@en
P2093
P1476
Poly(N-isopropylacrylamide)-ch ...... stem for ocular drug delivery.
@en
P2093
Qineng Ping
Wenbin Shen
Yanxia Cao
Zhihong Cheng
P304
P356
10.1016/J.JCONREL.2007.05.009
P407
P577
2007-05-17T00:00:00Z